Design, synthesis, and testing of difluoroboron-derivatized curcumins as near-infrared probes for in vivo detection of amyloid-beta deposits.

Amyloid-beta (Abeta) deposits have been identified as key players in the progression of Alzheimer's disease (AD). Recent evidence indicates that the deposits probably precede and induce the neuronal atrophy. Therefore, methods that enable monitoring the pathology before clinical symptoms are observed would be beneficial for early AD detection. Here, we report the design, synthesis, and testing of a curcumin-derivatized near-infrared (NIR) probe, CRANAD-2. Upon interacting with Abeta aggregates, CRANAD-2 undergoes a range of changes, which include a 70-fold fluorescence intensity increase, a 90 nm blue shift (from 805 to 715 nm), and a large increase in quantum yield. Moreover, this probe also shows a high affinity for Abeta aggregates (K(d) = 38.0 nM), a reasonable log P value (log P = 3), considerable stability in serum, and a weak interaction with albumin. After intravenous injection of this probe, 19-month-old Tg2576 mice exhibited significantly higher relative signal than that of the control mice over the same period of time. In summary, CRANAD-2 meets all the requirements for a NIR contrast agent for the detection of Abeta plaques both in vitro and in vivo. Our data point toward the feasibility of monitoring the progress of the disease by NIR imaging with CRANAD-2. In addition, we believe that our probe could be potentially used as a tool for drug screening.

[1]  Guoqing Zhang,et al.  Boron polylactide nanoparticles exhibiting fluorescence and phosphorescence in aqueous medium. , 2008, ACS nano.

[2]  R. Weissleder,et al.  Imaging in the era of molecular oncology , 2008, Nature.

[3]  D. Holtzman,et al.  Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease , 2008, Nature.

[4]  Anthony Harriman,et al.  The chemistry of fluorescent bodipy dyes: versatility unsurpassed. , 2008, Angewandte Chemie.

[5]  Scott B. Raymond,et al.  Smart optical probes for near-infrared fluorescence imaging of Alzheimer’s disease pathology , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  P. Scheltens,et al.  Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria , 2007, The Lancet Neurology.

[7]  B. Hyman,et al.  Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model , 2007, Journal of neurochemistry.

[8]  S. J. Payne,et al.  Multi-emissive difluoroboron dibenzoylmethane polylactide exhibiting intense fluorescence and oxygen-sensitive room-temperature phosphorescence. , 2007, Journal of the American Chemical Society.

[9]  Sangmi Jun,et al.  The aggregated state of amyloid-beta peptide in vitro depends on Cu2+ ion concentration. , 2007, Angewandte Chemie.

[10]  Keith A. Johnson,et al.  Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report. , 2007, Archives of neurology.

[11]  Eun Kyoung Ryu,et al.  Curcumin and dehydrozingerone derivatives: synthesis, radiolabeling, and evaluation for beta-amyloid plaque imaging. , 2006, Journal of medicinal chemistry.

[12]  Stephen Barlow,et al.  Bisdioxaborine polymethines with large third-order nonlinearities for all-optical signal processing. , 2006, Journal of the American Chemical Society.

[13]  B. Aggarwal,et al.  Curcumin (Diferuloylmethane) Down-Regulates Expression of Cell Proliferation and Antiapoptotic and Metastatic Gene Products through Suppression of IκBα Kinase and Akt Activation , 2006, Molecular Pharmacology.

[14]  B. Aggarwal,et al.  Curcumin: Getting Back to the Roots , 2005, Annals of the New York Academy of Sciences.

[15]  Sanjeev Banerjee,et al.  Curcumin Suppresses the Paclitaxel-Induced Nuclear Factor-κB Pathway in Breast Cancer Cells and Inhibits Lung Metastasis of Human Breast Cancer in Nude Mice , 2005, Clinical Cancer Research.

[16]  Brian J Bacskai,et al.  In vivo optical imaging of amyloid aggregates in brain: design of fluorescent markers. , 2005, Angewandte Chemie.

[17]  B. Aggarwal,et al.  Curcumin‐induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IκB kinase and nuclear factor κB activity and are independent of the B‐Raf/mitogen‐activated/extracellular signal‐regulated protein kinase pathway and the Akt pathway , 2005, Cancer.

[18]  D. V. Vander Jagt,et al.  Anti-oxidant activities of curcumin and related enones. , 2005, Bioorganic & medicinal chemistry.

[19]  Markus Rudin,et al.  In vivo detection of amyloid-β deposits by near-infrared imaging using an oxazine-derivative probe , 2005, Nature Biotechnology.

[20]  Nobuhisa Iwata,et al.  19F and 1H MRI detection of amyloid β plaques in vivo , 2005, Nature Neuroscience.

[21]  E. Masliah,et al.  Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease , 2005, Science.

[22]  Fusheng Yang,et al.  Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo* , 2005, Journal of Biological Chemistry.

[23]  Michael Garwood,et al.  In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent , 2004, Magnetic resonance in medicine.

[24]  Jun-Seok Lee,et al.  Solid-phase synthesis of styryl dyes and their application as amyloid sensors. , 2004, Angewandte Chemie.

[25]  G. Curran,et al.  Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood-brain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques. , 2004, Biochemistry.

[26]  L. Jullien,et al.  Diaroyl(methanato)boron difluoride compounds as medium-sensitive two-photon fluorescent probes. , 2004, Chemistry.

[27]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[28]  Thomas Wisniewski,et al.  Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging , 2003, Magnetic resonance in medicine.

[29]  B. Hyman,et al.  In Vivo Multiphoton Imaging of a Transgenic Mouse Model of Alzheimer Disease Reveals Marked Thioflavine‐S‐Associated Alterations in Neurite Trajectories , 2003, Journal of neuropathology and experimental neurology.

[30]  W. Klunk,et al.  Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. , 2001, Life sciences.

[31]  V. Lee.  Aβ immunization: Moving Aβ peptide from brain to blood , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Bin Zhang,et al.  In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease. , 2000 .

[33]  D. Selkoe,et al.  Translating cell biology into therapeutic advances in Alzheimer's disease , 1999, Nature.

[34]  Sarah Tomlin,et al.  Microtechnology: Laying it on thick , 1999, Nature.

[35]  Y. Pommier,et al.  Coumarin-based inhibitors of HIV integrase. , 1997, Journal of medicinal chemistry.

[36]  S. Younkin,et al.  Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.

[37]  Y. Chow,et al.  Exciplexes of (Dibenzoylmethanato)boron/Benzenes: The Control of Exciplex Electronic Structure , 1995 .

[38]  B. Miller,et al.  Zur Kenntnis der Farbreaktion zwischen Borsäure und Curcumin. II. Zur Konstitution des Rosocyanins und Rubrocurcumins , 1964 .

[39]  H. Roth,et al.  Zur Kenntnis der Farbreaktion zwischen Borsäure und Curcumin. I. Borinsäure‐Curcumin‐Komplexe , 1964 .